TCL Archive Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials September 26, 2014
TCL Archive NCI Staff Recommends Moving Cooperative Groups Into DCT, Increase Funding, Switch Emphasis July 4, 1975